These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 6363644

  • 1. Acute arterial fibrinoid deposition and ischaemic parenchymal damage of the kidney. Pathogenic factors in the development of malignant hypertension.
    Chatelain RE, Dardik BN, Shainoff JR.
    J Pathol; 1983 Oct; 141(2):125-42. PubMed ID: 6363644
    [Abstract] [Full Text] [Related]

  • 2. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
    van den Born BJ, Koopmans RP, van Montfrans GA.
    Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041
    [Abstract] [Full Text] [Related]

  • 3. Malignant hypertension in Brattleboro (vasopressin-deficient) rats.
    Woods RL, Abrahams JM, Kincaid-Smith P, Johnston CI.
    J Hypertens; 1983 Jun; 1(1):37-43. PubMed ID: 6397512
    [Abstract] [Full Text] [Related]

  • 4. Morphometric evaluation of the renal arterial system of Dahl salt-sensitive and salt-resistant rats on a high salt diet. II. Interlobular arteries and intralobular arterioles.
    Hampton JA, Bernardo DA, Khan NA, Lacher DA, Rapp JP, Gohara AF, Goldblatt PJ.
    Lab Invest; 1989 Jun; 60(6):839-46. PubMed ID: 2733384
    [Abstract] [Full Text] [Related]

  • 5. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
    Mitchell KD, Bagatell SJ, Miller CS, Mouton CR, Seth DM, Mullins JJ.
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
    [Abstract] [Full Text] [Related]

  • 6. Effect of DOCA-salt on angiotensin dependency and surgical reversal of hypertension in two-kidney, one clip renal hypertensive rats.
    Takata Y, Doyle AE.
    J Hypertens; 1983 Jun; 1(1):57-63. PubMed ID: 6397514
    [Abstract] [Full Text] [Related]

  • 7. [The malignant hypertension syndrome: incontrovertible and questionable truths].
    Shulutko BI, Konstantinov IuV.
    Ter Arkh; 1990 Jun; 62(6):121-4. PubMed ID: 2218909
    [Abstract] [Full Text] [Related]

  • 8. Renal vascular lesions in severe hypertension. Transitional changes from benign to malignant nephrosclerosis.
    Akikusa B, Kondo Y, Irabu N, Shigematsu H.
    Acta Pathol Jpn; 1983 Mar; 33(2):323-31. PubMed ID: 6869004
    [Abstract] [Full Text] [Related]

  • 9. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J, Mladenović Lj.
    Srp Arh Celok Lek; 1996 Mar; 124(9-10):246-50. PubMed ID: 9102857
    [Abstract] [Full Text] [Related]

  • 10. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
    Peco-Antić A, Nastić-Mirić D, Babić D, Kostić M.
    Srp Arh Celok Lek; 1999 Mar; 127(9-10):305-11. PubMed ID: 10649899
    [Abstract] [Full Text] [Related]

  • 11. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S, Bernheim J, Podjarny E.
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [Abstract] [Full Text] [Related]

  • 12. Renin-angiotensin-aldosterone system in arterial hypertension.
    Horký K, Gregorová I.
    Cor Vasa; 1980 Jan; 22(1-2):59-73. PubMed ID: 6995018
    [Abstract] [Full Text] [Related]

  • 13. An ultrastructural analysis of renal arterioles in benign and malignant essential hypertensions.
    Mandal AK, Frohlich ED, Nordquist J.
    Ann Clin Lab Sci; 1977 Jan; 7(2):158-68. PubMed ID: 851350
    [Abstract] [Full Text] [Related]

  • 14. Vascular lesions and angiotensin in malignant hypertension in the absence of vasopressin.
    Woods RL, Abrahams JM, Kincaid-Smith P, Johnston CI.
    Clin Exp Pharmacol Physiol; 1982 Jan; 9(3):297-301. PubMed ID: 6754178
    [Abstract] [Full Text] [Related]

  • 15. Elevated plasma catecholamines and adrenal phenylethanolamine N-methyl transferase in experimental renal hypertension.
    Chatelain RE, Bridle PA, Manniello MJ, Dardik BN.
    J Hypertens Suppl; 1986 Dec; 4(6):S240-3. PubMed ID: 3302151
    [Abstract] [Full Text] [Related]

  • 16. Male gender and not the severity of hypertension is associated with end-organ damage in aged stroke-prone spontaneously hypertensive rats.
    Masineni SN, Chander PN, Singh GD, Powers CA, Stier CT.
    Am J Hypertens; 2005 Jun; 18(6):878-84. PubMed ID: 15925751
    [Abstract] [Full Text] [Related]

  • 17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 18. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension.
    Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K.
    J Hypertens; 1995 Jan; 13(1):155-60. PubMed ID: 7759846
    [Abstract] [Full Text] [Related]

  • 19. Intrauterine growth restriction in rats is associated with hypertension and renal dysfunction in adulthood.
    Battista MC, Oligny LL, St-Louis J, Brochu M.
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E124-31. PubMed ID: 12067852
    [Abstract] [Full Text] [Related]

  • 20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.